| Patent | Date |
|---|
Immunocompetent Cell and Expression Vector Expressing Regulatory Factors of Immune Function
App 20220273723 - Tamada; Koji ; et al. | 2022-09-01 |
Hsp70-derived Peptide, Pharmaceutical Composition For Treating Or Preventing Cancer Using Same, Immunity Inducer, And Method For Producing Antigen Presenting Cell
App 20220193213 - MIYAKAWA; Tomoya ; et al. | 2022-06-23 |
MEDICINE FOR TREATING CANCER BY ADMINISTERING A TOLL-LIKE RECEPTOR AGONIST AND LAG-3 IgG FUSION PROTEIN
App 20220175915 - MIYAKAWA; Tomoya ; et al. | 2022-06-09 |
Immunocompetent cell and expression vector expressing regulatory factors of immune function
Grant 11,337,997 - Tamada , et al. May 24, 2 | 2022-05-24 |
Chimeric Receptor That Recognizes Engineered Site In Antibody
App 20220143094 - Sakurai; Mika ; et al. | 2022-05-12 |
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
Grant 11,304,997 - Miyakawa , et al. April 19, 2 | 2022-04-19 |
Therapeutic And Prophylactic Agent For Glioma, Brain Tumor Malignancy Marker, Brain Tumor Prognostic Marker, Method For Determining Malignancy And Prognosis Of Brain Tumor And Antibody Inhibiting Tumor Proliferation
App 20220105122 - MIYAZONO; Kohei ; et al. | 2022-04-07 |
Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
Grant 11,291,718 - Miyakawa , et al. April 5, 2 | 2022-04-05 |
Universal Anti-tag Chimeric Antigen Receptor-expressing T Cells And Methods Of Treating Cancer
App 20210330769 - DAVILA; Eduardo ; et al. | 2021-10-28 |
Car Expression Vector And Car-expressing T Cells
App 20210253726 - Tamada; Koji ; et al. | 2021-08-19 |
Chimeric Antigen Receptor
App 20210122831 - TAMADA; Koji ; et al. | 2021-04-29 |
Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer
Grant 10,973,893 - Davila , et al. April 13, 2 | 2021-04-13 |
CAR expression vector and CAR-expressing T cells
Grant 10,906,984 - Tamada , et al. February 2, 2 | 2021-02-02 |
Medicine
App 20210000916 - MIYAKAWA; Tomoya ; et al. | 2021-01-07 |
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
Grant 10,875,900 - Miyakawa , et al. December 29, 2 | 2020-12-29 |
Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
Grant 10,842,848 - Miyakawa , et al. November 24, 2 | 2020-11-24 |
Enhancer For T-cells Or B-cells Having Memory Function, Malignant Tumor Recurrence Inhibitor, And Inducer For Inducing Memory Function In T-cells Or B-cells
App 20200352997 - Tamada; Koji ; et al. | 2020-11-12 |
Immunocompetent Cell That Expresses A Cell Surface Molecule Specifically Recognizing Human Mesothelin, Il-7 And Ccl19
App 20200323920 - TAMADA; Koji ; et al. | 2020-10-15 |
Anti-GPC3 antibody
Grant 10,781,249 - Tamada , et al. Sept | 2020-09-22 |
Anti-GPC3 antibody
Grant 10730935 - | 2020-08-04 |
Muc1-derived Peptide, And Pharmaceutical Composition For Treatment Or Prevention Of Cancer, Immunity-inducing Agent And Method F
App 20200181195 - MIYAKAWA; TOMOYA ; et al. | 2020-06-11 |
Peptide Derived From Gpc3, Pharmaceutical Composition For Treatment Or Prevention Of Cancer Using Same, Immunity Inducer, And Me
App 20200157163 - Miyakawa; Tomoya ; et al. | 2020-05-21 |
Hsp70-derived Peptide, Pharmaceutical Composition For Treating Or Preventing Cancer Using Same, Immunity Inducer, And Method For
App 20200121772 - Miyakawa; Tomoya ; et al. | 2020-04-23 |
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
Grant 10,590,179 - Miyakawa , et al. | 2020-03-17 |
Medicine
App 20200038508 - MIYAKAWA; Tomoya ; et al. | 2020-02-06 |
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
Grant 10,537,626 - Miyakawa , et al. Ja | 2020-01-21 |
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
Grant 10,526,388 - Miyakawa , et al. J | 2020-01-07 |
Anti-gpc3 Antibody
App 20190367634 - TAMADA; KOJI ; et al. | 2019-12-05 |
Anti-gpc3 Antibody
App 20190359698 - TAMADA; Koji ; et al. | 2019-11-28 |
Car Expression Vector And Car-expressing T Cells
App 20190322755 - TAMADA; Koji ; et al. | 2019-10-24 |
Car expression vector and car-expressing T cells
Grant 10,316,102 - Tamada , et al. | 2019-06-11 |
Immunocompetent Cell And Expression Vector Expressing Regulatory Factors Of Immune Function
App 20190099446 - TAMADA; Koji ; et al. | 2019-04-04 |
Peptide Derived From Gpc3, Pharmaceutical Composition For Treatment Or Prevention Of Cancer Using Same, Immunity Inducer, And Method For Producing Antigen-presenting Cells
App 20190062389 - Miyakawa; Tomoya ; et al. | 2019-02-28 |
HSP70-Derived Peptide, Pharmaceutical Composition for Treating or Preventing Cancer Using Same, Immunity Inducer, and Method for Producing Antigen Presenting Cell
App 20180169199 - Miyakawa; Tomoya ; et al. | 2018-06-21 |
Peptide Derived From Gpc3, Pharmaceutical Composition For Treatment Or Prevention Of Cancer Using The Same, Immunity Inducer, And Method For Producing Antigen-presenting Cells
App 20180105567 - MIYAKAWA; Tomoya ; et al. | 2018-04-19 |
Medicine
App 20180071362 - MIYAKAWA; Tomoya ; et al. | 2018-03-15 |
Muc1-derived Peptide, And Pharmaceutical Composition For Treatment Or Prevention Of Cancer, Immunity-inducing Agent And Method For Manufacturing Antigen Presenting Cell Using Same
App 20180057531 - MIYAKAWA; Tomoya ; et al. | 2018-03-01 |
Car Expression Vector And Car-expressing T Cells
App 20170291953 - TAMADA; Koji ; et al. | 2017-10-12 |
Universal Anti-tag Chimeric Antigen Receptor-expressing T Cells And Methods Of Treating Cancer
App 20160129109 - Davila; Eduardo ; et al. | 2016-05-12 |
Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer
Grant 9,233,125 - Davila , et al. January 12, 2 | 2016-01-12 |
Universal Anti-tag Chimeric Antigen Receptor-expressing T Cells And Methods Of Treating Cancer
App 20130287752 - Davila; Eduardo ; et al. | 2013-10-31 |
Compositions and methods for the treatment of immunologic disorders
Grant 8,440,185 - Chen , et al. May 14, 2 | 2013-05-14 |
Compositions And Methods For Treating Inflammation
App 20130011835 - Chen; Lieping ; et al. | 2013-01-10 |
Inhibition of B7-H1/CD80 interaction and uses thereof
App 20110280877 - Tamada; Koji | 2011-11-17 |
Immunotherapy for Contact Dermatitis Using Co-Signal Regulation
App 20110268741 - Tamada; Koji | 2011-11-03 |
Novel Compositions And Methods For Stimulating Erythropoiesis In A Mammal
App 20100203047 - Tamada; Koji ; et al. | 2010-08-12 |
Compositions and Methods for Treating Inflammation
App 20090214519 - Chen; Lieping ; et al. | 2009-08-27 |
Compositions And Methods For The Treatment Of Immunologic Disorders
App 20080187542 - Chen; Lieping ; et al. | 2008-08-07 |
Toy with floating ornament enclosed in transparent vessel
Grant 4,582,498 - Tamada April 15, 1 | 1986-04-15 |
Invertible timer
Grant 3,935,702 - Tamada February 3, 1 | 1976-02-03 |
| 